Cargando…

Novel Antiviral Activity of Ethyl 3-Hydroxyhexanoate Against Coxsackievirus B Infection

Coxsackievirus group B (CVB) is a member of the genus Enterovirus in the family Picornaviridae. CVB infection has been implicated as a major etiologic agent of viral myocarditis, dilated cardiomyopathy, meningitis, and pancreatitis among children and young adults. Until date, no antiviral agent has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olasunkanmi, Oluwatayo Israel, Mageto, James, Avala Ntsigouaye, Juval, Yi, Ming, Fei, Yanru, Chen, Yang, Chen, Sijia, Xu, Weizhen, Lin, Lexun, Zhao, Wenran, Wang, Yan, Zhong, Zhao-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048257/ https://www.ncbi.nlm.nih.gov/pubmed/35495645 http://dx.doi.org/10.3389/fmicb.2022.875485

Ejemplares similares

Virus-Induced Cytoplasmic Aggregates and Inclusions are Critical Cellular Regulatory and Antiviral Factors
por: Olasunkanmi, Oluwatayo Israel, et al.
Publicado: (2020)

Combination of dasabuvir and PSI-6206 for the treatment of coxsackievirus B3 infection
por: Olasunkanmi, Oluwatayo Israel, et al.
Publicado: (2022)

Circular RNA circ_0076631 promotes coxsackievirus B3 infection through modulating viral translation by sponging miR-214-3p
por: Qin, Ying, et al.
Publicado: (2022)

MiR-146a down-regulates inflammatory response by targeting TLR3 and TRAF6 in Coxsackievirus B infection
por: Fei, Yanru, et al.
Publicado: (2020)

Protein 2B of Coxsackievirus B3 Induces Autophagy Relying on Its Transmembrane Hydrophobic Sequences
por: Wu, Heng, et al.
Publicado: (2016)

The Capsid Protein VP1 of Coxsackievirus B Induces Cell Cycle Arrest by Up-Regulating Heat Shock Protein 70
por: Wang, Yao, et al.
Publicado: (2019)

Blocking of EGFR Signaling Is a Latent Strategy for the Improvement of Prognosis of HPV-Induced Cancer
por: Qiu, Jianfa, et al.
Publicado: (2021)

Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections
por: Wu, Shuo, et al.
Publicado: (2014)

A functional nuclear localization sequence in the VP1 capsid protein of coxsackievirus B3
por: Wang, Tianying, et al.
Publicado: (2012)

Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination
por: Ji, Wangquan, et al.
Publicado: (2021)

MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence
por: Tong, Lei, et al.
Publicado: (2013)

Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response
por: Wang, Yan, et al.
Publicado: (2018)

Effect of Monomers of 3-Hydroxyhexanoate on Properties of Copolymers Poly(3-Hydroxybutyrate-co 3-Hydroxyhexanoate)
por: Volova, Tatiana G., et al.
Publicado: (2023)

Antiviral Effects of Menthol on Coxsackievirus B
por: Taylor, David J.R., et al.
Publicado: (2020)

Coxsackievirus A16 in Southern Vietnam
por: Nhu, Le Nguyen Truc, et al.
Publicado: (2021)

Coxsackievirus A6 Induces Necroptosis for Viral Production
por: Zhang, Shuxia, et al.
Publicado: (2020)

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011)

One-Step Reverse-Transcription Recombinase Polymerase Amplification Using Lateral Flow Strips for the Detection of Coxsackievirus A6
por: Xie, Jia, et al.
Publicado: (2021)

Antiviral and immunoregulatory effects of curcumin on coxsackievirus B3-infected hepatitis
por: Lin, Yu-Jheng, et al.
Publicado: (2023)

Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches
por: Huang, Sichao, et al.
Publicado: (2022)

Coxsackievirus B3 infection induces glycolysis to facilitate viral replication
por: Qian, Yujie, et al.
Publicado: (2022)

Eupafolin and Ethyl Acetate Fraction of Kalanchoe gracilis Stem Extract Show Potent Antiviral Activities against Enterovirus 71 and Coxsackievirus A16
por: Wang, Ching-Ying, et al.
Publicado: (2013)

Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)-based scaffolds for tissue engineering
por: Chang, H.M., et al.
Publicado: (2014)

Tung Oil-Based Production of High 3-Hydroxyhexanoate-Containing Terpolymer Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate-co-3-Hydroxyhexanoate) Using Engineered Ralstonia eutropha
por: Lee, Hye Soo, et al.
Publicado: (2021)

Genetic characterization and molecular epidemiology of Coxsackievirus A12 from mainland China during 2010–2019
por: Guo, Qin, et al.
Publicado: (2022)

Cleavage of Desmosomal Cadherins Promotes γ-Catenin Degradation and Benefits Wnt Signaling in Coxsackievirus B3-Induced Destruction of Cardiomyocytes
por: Zhao, Guangze, et al.
Publicado: (2020)

Cleavage of Grb2-Associated Binding Protein 2 by Viral Proteinase 2A during Coxsackievirus Infection
por: Deng, Haoyu, et al.
Publicado: (2017)

The antiviral effect of jiadifenoic acids C against coxsackievirus B3
por: Ge, Miao, et al.
Publicado: (2014)

Films Based on a Blend of PVC with Copolymer of 3-Hydroxybutyrate with 3-Hydroxyhexanoate
por: Belukhichev, Evgeniy V., et al.
Publicado: (2020)

Effect of Graphene Oxide on the Properties of Poly(3-Hydroxybutyrate-co-3-Hydroxyhexanoate)
por: Díez-Pascual, Ana M.
Publicado: (2021)

The regulation of antiviral activity of interferon epsilon
por: Zhao, Fu-Rong, et al.
Publicado: (2022)

The development and characterization of a stable Coxsackievirus A16 infectious clone with Nanoluc reporter gene
por: Yu, Rui, et al.
Publicado: (2023)

Antiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3
por: Kim, Min Ji, et al.
Publicado: (2014)

Antiviral Activity of Chrysin Derivatives against Coxsackievirus B3 in vitro and in vivo
por: Song, Jae-Hyoung, et al.
Publicado: (2015)

Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming
por: Kespohl, Meike, et al.
Publicado: (2020)

Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation
por: Yin, Zhichao, et al.
Publicado: (2021)

Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul
por: CEYLAN, AYSE N., et al.
Publicado: (2019)

Screening of a new candidate coxsackievirus B1 vaccine strain based on its biological characteristics
por: Zhang, Ming, et al.
Publicado: (2023)

N4BP3 Regulates RIG-I-Like Receptor Antiviral Signaling Positively by Targeting Mitochondrial Antiviral Signaling Protein
por: Wang, Chen, et al.
Publicado: (2021)

CircDDX17 enhances coxsackievirus B3 replication through regulating miR-1248/NOTCH receptor 2 axis
por: Liu, Tingjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_93gqb13jet472fcu9e49a23bj0